Covance plans closures – and expansions – as it aims to 'right-size'
LabCorp’s Covance is implementing a two-phase plan intended to create operational efficiencies over the next three years.
LabCorp’s Covance is implementing a two-phase plan intended to create operational efficiencies over the next three years.
Bracket has launched a Bring Your Own Device (BYOD) electronic patient-reported outcome (ePRO) Ph III study in Japan.
Pharco Pharmaceuticals has granted a license to make, sell and export the hepatitis C drug ravidasvir (RAV) to Medicines Patent Pool (MPP).
DISPATCHES FROM BPI EUROPE 2017
Sanofi Pasteur says heavy investment in messenger RNA (mRNA) is warranted as such technology could revolutionise vaccine development and manufacturing.
The UK MHRA saw an increase in sterility issues at drug plants in 2016 although quality system problems remained the most common deficiency seen during inspections.
EAG Laboratories is expanding its Columbia, Missouri-based cell bioassay laboratory to support multiple development programs.